CHAPEL HILL, N.C., July 19, 2013 /PRNewswire/ -- The bio-pharmaceutical marketplace – and the diabetes therapeutic area in particular – continues to evolve as new medicines and technologies create valuable market opportunities. It's in this competitive and challenging environment that organizations with new Diabetes products are scrutinizing their strategies and tactics to support market education.
When it comes to timing medical education efforts directed at healthcare providers, Diabetes teams follow the Specialist to Primary Care Physician to Nurse Practitioner cascade. However, they introduce targeting to Primary Care Physicians and Nurse Practitioners somewhat earlier – at two year pre-launch – than other therapeutic areas, according to new research from Best Practices, LLC. This likely reflects the importance of PCPs and Nurses in diabetes treatment.
The report, Shaping the Marketplace to Support Successful Diabetes Product Launches: Tactics for Educating KOLs, Physicians, Patients and Payers, contains a plethora of benchmark metrics on the most effective physician, payer and patient education practices conducted from clinical development through launch. The 160-page report contains almost 500 metrics to help inform launch leaders in the Diabetes area on the most effective type and timing of market education practices during the full development cycle.
The research - which includes Diabetes and total benchmark class segments - attracted 34 executives and managers from 26 leading pharmaceutical, biotech and medical device companies, including 13 of the Top 20 pharmaceutical companies. Additionally, the research reflects on nine deep-dive interviews with selected participants.
Key Topics of this report include:
Executives and managers involved in market education efforts for new products can use this research to compare their market education tactics and strategies with those of leading organizations.
Download a complimentary report summary, including sample best practices drawn from extensive primary research with executives at leading companies at: http://www3.best-in-class.com/rr1224.htm.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.
|SOURCE Best Practices, LLC|
Copyright©2012 PR Newswire.
All rights reserved